Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.

Lindsley named Edward P. Evans Investigator

Coleman Lindsley and Michael D. Lewis
Pictured at the celebration: Lindsley (left) and foundation President Michael D. Lewis, PhD.

Spring 2024
By Lori Dougherty
Photography by Bryce Vickmark

Coleman Lindsley, MD, PhD, was recognized as the Edward P. Evans Investigator in MDS research at Dana-Farber at an event in 2023. Lindsley’s lab focuses on the biology and treatment of myeloid malignancies, with specific emphases on defining genetic pathways of progression, mechanisms of familial leukemia predisposition, and understanding donor and recipient factors that drive clinical outcomes after bone marrow transplantation. The event also celebrated the Edward P. Evans Foundation, which established both the investigatorship and the Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at the Institute with a visionary $5 million grant, the largest gift to MDS research in Dana-Farber history.

,

More stories:

Copy link
Powered by Social Snap